1. Home
  2. ATAI vs FPF Comparison

ATAI vs FPF Comparison

Compare ATAI & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • FPF
  • Stock Information
  • Founded
  • ATAI 2018
  • FPF 2013
  • Country
  • ATAI Netherlands
  • FPF United States
  • Employees
  • ATAI N/A
  • FPF N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • FPF Trusts Except Educational Religious and Charitable
  • Sector
  • ATAI Health Care
  • FPF Finance
  • Exchange
  • ATAI Nasdaq
  • FPF Nasdaq
  • Market Cap
  • ATAI 1.1B
  • FPF 1.2B
  • IPO Year
  • ATAI 2021
  • FPF N/A
  • Fundamental
  • Price
  • ATAI $5.84
  • FPF $19.06
  • Analyst Decision
  • ATAI Strong Buy
  • FPF
  • Analyst Count
  • ATAI 5
  • FPF 0
  • Target Price
  • ATAI $14.00
  • FPF N/A
  • AVG Volume (30 Days)
  • ATAI 7.0M
  • FPF 186.7K
  • Earning Date
  • ATAI 11-14-2025
  • FPF 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • FPF 8.08%
  • EPS Growth
  • ATAI N/A
  • FPF N/A
  • EPS
  • ATAI N/A
  • FPF N/A
  • Revenue
  • ATAI $2,309,000.00
  • FPF N/A
  • Revenue This Year
  • ATAI $736.04
  • FPF N/A
  • Revenue Next Year
  • ATAI N/A
  • FPF N/A
  • P/E Ratio
  • ATAI N/A
  • FPF N/A
  • Revenue Growth
  • ATAI 510.85
  • FPF N/A
  • 52 Week Low
  • ATAI $1.04
  • FPF $13.91
  • 52 Week High
  • ATAI $6.75
  • FPF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 54.11
  • FPF 56.81
  • Support Level
  • ATAI $5.50
  • FPF $18.91
  • Resistance Level
  • ATAI $6.23
  • FPF $19.06
  • Average True Range (ATR)
  • ATAI 0.47
  • FPF 0.14
  • MACD
  • ATAI -0.05
  • FPF 0.04
  • Stochastic Oscillator
  • ATAI 36.10
  • FPF 94.30

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: